Newsroom

News
30 young scientists came together from 16 – 20 April 2018 at Bayer in Berlin for the ENLIGHT-TEN summer school on translational research and medicines development. The summer school introduced the participants to the knowledge, philosophy and tools needed in translational research and medicine development, empowering them to make a difference in translational medicine. A faculty of 13 high profile professionals from Industry, Academia and Biotech introduced the basics of the medicines development process including real life case studies.
24.05.2018
Eine neue intelligente Software kann zukünftig helfen, krankheitserregende Salmonellen-Stämme frühzeitig zu identifizieren.
News
A new machine learning tool that can detect whether emerging strains of the bacterium, Salmonella are more likely to cause dangerous bloodstream infections rather than food poisoning has been developed. The tool, created by a scientist at the Wellcome Sanger Institute and her collaborators at the University of Otago, New Zealand and the Helmholtz Institute for RNA-based Infection Research, a site of the Helmholtz Centre for Infection Research, Germany, greatly speeds up the process for identifying the genetic changes underlying new invasive types of Salmonella that are of public health concern.
23.05.2018
v.l.n.r.: Dirk Heinz (HZI), Rolf Müller (HIPS), Anke Kaysser-Pyzalla (TU Braunschweig), Frieda Kage (TU Braunschweig), Daniel Todt (TWINCORE), Dieter Jahn (TU Braunschweig) und Hansjörg Hauser (HZI / Förderverein).
News
Numerous pathogens are capable of becoming resistant to medications, such as antibiotics, which allows them to protect themselves from the antibiotics and to spread vigorously. Moreover, many diseases cannot be treated sufficiently because there are no effective drugs available. The search for new drugs is very laborious and resource-consuming. Natural products, so-called secondary metabolites, that are produced by bacteria, fungi and plants are some interesting candidates in this context. Especially soil-dwelling myxobacteria produce a large variety of natural agents which they use to eliminate microbial competitors or enemies. This is the special field of natural product researcher Prof Rolf Müller. Honouring his outstanding research aimed at the discovery of microbial natural products mainly from myxobacteria, the German pharmacist has been awarded this year's Inhoffen Award, to be presented on 17 May. Müller directs the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a branch site of the Helmholtz Centre for Infection Research (HZI) and the Saarland University.
09.05.2018
Scientists stand in front of a screen on which the online monitoring system SORMAS is displayed.
Story
In autumn 2017, Nigeria suspected an outbreak of human monkey pox. Immediately, epidemiologists adapted their online disease surveillance system and travelled to Nigeria to support the locals. The 2014 Ebola outbreak in West Africa revealed an urgent need of efficient disease surveillance systems, because it became evident that the outcome of an epidemic also depends on how fast disease control measures are implemented. HZI scientists from the Department of Epidemiology, led by Gérard Krause, teamed up with Nigerian scientists and developed a mobile-based application, which allows real-time data collection and application of disease control measures called Surveillance, Outbreak Response Management and Analysis System (SORMAS).
01.05.2018
Im Fokus der WASA-Studie: Alle interessierten Ärzte und Ärztinnen, insbesondere aus dem praktischen und allgemeinmedizinischen Bereich sowie hausärztlich tätige Internisten und Internistinnen der Region Südostniedersachsen.
News
Antibiotics are still overprescribed in primary care and prescriptions are often not in line with the recommendations and guidelines set out by the medical associations. For this reason, the Helmholtz Centre for Infection Research (HZI) and the Hygienenetzwerk Südostniedersachsen, the City of Braunschweig, the Klinikum Braunschweig, and the AOK Niedersachsen have developed a project called "Effectiveness of training on antibiotic prescription routine for General Practitioners (GP)" (Wirksamkeit von Antibiotikaschulungen in der niedergelassenen Ärzteschaft, WASA) that is funded by the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG).
27.04.2018
Das Forscherteam in Thailand.
News
Fungi are considered a natural source of antimicrobials in drug discovery. So far, little research has been done on the fungal diversity of tropical regions which promises novel compounds with antibiotic activity. An international research group led by Prof Marc Stadler from the Helmholtz Centre for Infection Research (HZI) has discovered novel metabolites that displayed antimicrobial and nematicidal responses. These substances are produced by a previously unknown type of fungus, which the team discovered during their study in the rainforest of Thailand. Results of their study were published in the scientific journal MycoKeys.
24.04.2018

HZI in the media

could be reintroduced at any time. Epidemiologists at the Helmholtz Center for Infection Research (HZI) have now shown that many people do

23.10.2025
|
MSN.com

... eingeschleppt werden könnte. Epidemiolog:innen des Helmholtz-Zentrums für Infektionsforschung (HZI) haben nun gezeigt, dass ...

23.10.2025
|
innovations report

this development, a research team at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in collaboration with the Swiss

22.10.2025
|
Phys.org

Malaria-Medikamentes ermöglichen könnte. Das HIPS ist ein Standort des Helmholtz-Zentrums für Infektionsforschung in Zusammenarbeit mit ...

22.10.2025
|
Verband Deutscher Biologen e.V.

(Bild: DOI: 10.1021/jacs.5c08354 / Hips / CC BY 4.0) Wissenschaftler am Hips entwickelten eine Plattform zur Produktion von Furanoliden, die effektiv gegen Bakterien und Krebszellen wirken können und vielversprechende Wirkstoffe darstellen.

21.10.2025
|
PROCESS

at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), in partnership with the Helmholtz Centre for Infection Research (HZI

20.10.2025
|
Bioengineer.org

their biological activity. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

20.10.2025
|
Phys.org

... die Abteilung „Experimentelle Immunologie“ am Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig, lehrt als Professor an ...

17.10.2025
|
Deutsches Ärzteblatt

Einrichtungen als nationale assoziierte Partner: das Helmholtz-Zentrum für Infektionsforschung Braunschweig, die Universität Bayreuth, das

17.10.2025
|
AlphaGalileo

... diesem Ergebnis kommt ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) in Zusammenarbeit mit der ...

14.10.2025
|
Deutsches Ärzteblatt

Individualisierte Infektionsmedizin, einer gemeinsamen Einrichtung des Helmholtz-Zentrums für Infektionsforschung und der MHH. Bis zuletzt

13.10.2025
|
Springer

Ein Grippe-Test könnte in Zukunft womöglich sehr schnell gehen: einfach ein Kaugummi kauen. Ein deutsches ...

09.10.2025
|
Apotheken Umschau

Register now for the HZI-Newsletter